Drug Development – Consulting HUB

Consulting

Drug Development Consulting

Drug development requires integrated quantitative strategy across pharmacology, modeling, and statistical evaluation. I support therapeutic programs with rigorous analytical frameworks from early research through submission.

Consulting Services

Quantitative methods play a critical role in guiding development decisions. Below are consulting areas focused on strengthening analytical integrity and scientific defensibility.

Advanced Biochemistry

Statistical support for biochemical research, protein analysis, enzyme kinetics, metabolic pathway studies, and molecular interaction modeling.

Chemistry Statistics

Specialized statistical methods for analytical chemistry, quality control data, chemical process optimization, and method validation in pharmaceutical and industrial settings.

Pharmacology & Drug Development

Quantitative pharmacology and statistical strategy guiding early-phase development through regulatory submission.

Advanced Pharmacokinetics & Pharmacodynamics Consulting

Advanced PK/PD modeling and exposure-response analysis to support dose selection, optimization, and regulatory-ready drug development strategies.

Biosimilar & Advanced Therapy Statistics

Statistical strategy and comparative analytics for biosimilars and advanced therapies, supporting equivalence, safety, and regulatory submissions.

Professional Background & Expertise

"Academic Excellence and Statistical Leadership"